Blackstone Labs AbNORMAL – 19-Nor DHEA Prohormone | 60 Tablets

Blackstone Labs AbNORMAL is a three-form 19-Nor-DHEA prohormone supplement featuring a 50 mg proprietary blend of 19-NorAndrost-4-ene-3β-ol,17-one and its decanoate and enanthate derivatives. Designed for the bodybuilding supplement category, AbNORMAL combines related androgen precursors in a single-tablet formulation.

The product incorporates phosphatidylcholine and hydroxypropyl-beta-cyclodextrin among its delivery-related ingredients.

Each bottle contains 60 tablets, with 50 mg of the combined 19-Nor-DHEA blend per tablet.

What Is Blackstone Labs AbNORMAL?

Blackstone Labs AbNORMAL is formulated around the 19-nor family of steroid hormone precursors.

The term 19-nor describes steroid structures that lack the carbon-19 methyl group found in testosterone. This structural distinction is also associated with nandrolone, an anabolic-androgenic steroid chemically known as 19-nortestosterone.

AbNORMAL contains three versions of a related 19-nor precursor rather than a combination of unrelated androgenic compounds.

Its formula includes:

• 19-NorAndrost-4-ene-3β-ol,17-one

• 19-NorAndrost-4-ene-3β-ol,17-one Decanoate

• 19-NorAndrost-4-ene-3β-ol,17-one Enanthate

Together, these ingredients constitute the 50 mg proprietary blend.

The individual amounts are not disclosed.

Blackstone Labs AbNORMAL Ingredients Explained

19-NorAndrost-4-ene-3β-ol,17-one

The base compound is commonly associated with 19-Nor-DHEA, also called 19-Norandrostenolone.

It belongs to a family of steroid precursors associated with metabolic pathways toward nandrolone-related androgens.

Nandrolone interacts with androgen receptors and has established anabolic-androgenic pharmacological activity.

However, an androgen precursor is not pharmacologically equivalent to administering nandrolone itself.

The quantity converted into active metabolites following oral administration can depend on absorption, enzyme activity, first-pass metabolism, and other physiological factors.

Product-specific human studies establishing conversion efficiency for AbNORMAL are not available.

19-Nor-DHEA Decanoate

The formula also contains the decanoate ester derivative of its parent 19-nor compound.

Decanoate is derived from decanoic acid, a ten-carbon fatty acid.

Adding a decanoate ester changes the physicochemical properties of a steroid-related molecule, including its molecular weight and lipophilicity.

In certain pharmaceutical formulations, esterification can influence absorption and release characteristics.

However, the behavior of orally administered 19-Nor-DHEA Decanoate cannot be reliably predicted from injectable nandrolone decanoate.

Its release rate and biological availability in AbNORMAL have not been established in controlled human pharmacokinetic studies.

19-Nor-DHEA Enanthate

The third component is 19-NorAndrost-4-ene-3β-ol,17-one Enanthate.

Enanthate is a seven-carbon fatty-acid-derived ester commonly encountered in steroid chemistry.

Like the decanoate modification, the enanthate group changes the chemical properties of the parent compound.

Blackstone Labs uses these ester variations as part of its proprietary formulation strategy.

Although different ester groups may influence how a compound behaves in biological systems, the presence of multiple esters does not independently demonstrate sustained release or stable blood concentrations.

How Does 19-Nor-DHEA Work?

19-Nor-DHEA is marketed as a precursor associated with nandrolone-related steroid metabolism.

The proposed metabolic pathway involves enzyme-mediated transformations of 19-nor steroid precursors into other androgen-related compounds.

Androgens can interact with androgen receptors in skeletal muscle and other tissues. These receptors participate in biological processes involving protein metabolism, reproductive function, and endocrine regulation.

However, structural similarity to an anabolic steroid does not establish equivalent potency.

AbNORMAL has not been demonstrated in controlled human trials to produce predictable nandrolone concentrations, muscle growth, or strength improvements.

AbNORMAL and Liposomal Delivery Technology

Blackstone Labs markets AbNORMAL as incorporating a specialized liposomal delivery approach.

Its other ingredients include phosphatidylcholine, a phospholipid commonly used in lipid-based formulations, and hydroxypropyl-beta-cyclodextrin, an excipient capable of modifying the solubility of certain compounds.

These materials have established applications in pharmaceutical formulation science.

Nevertheless, their presence does not demonstrate that AbNORMAL achieves a specific absorption percentage.

Claims of 95% or 99% bioavailability would require controlled pharmacokinetic testing of the finished formulation.

Likewise, oral administration does not automatically bypass hepatic first-pass metabolism.

Blackstone Labs AbNORMAL vs. Decabolin

Blackstone Labs AbNORMAL and Hi-Tech Pharmaceuticals Decabolin both feature 19-nor-related compounds, but their formulations differ.

Blackstone Labs AbNORMAL combines three related forms of 19-Nor-DHEA in a 50 mg proprietary blend, including the base compound and two ester derivatives.

Hi-Tech Pharmaceuticals Decabolin lists 75 mg of a single 19-Nor-DHEA decanoate derivative per tablet.

Because AbNORMAL does not disclose the quantity of each constituent, directly comparing the amount of the parent precursor between the products is not possible.

Neither formulation should be assumed to provide the same pharmacological effects as prescription nandrolone.

AbNORMAL and Bodybuilding

Blackstone Labs markets AbNORMAL toward bodybuilding enthusiasts interested in muscle development, strength training, and androgen-related supplementation.

Its manufacturer-marketed applications include:

• Lean muscle development

• Strength-focused resistance training

• Muscle mass and body composition

• Androgen-related metabolic pathways

• Physique-oriented bodybuilding

These are manufacturer-marketed objectives, not clinically demonstrated outcomes of the finished product.

The presence of multiple 19-nor derivatives does not establish superior effectiveness compared with a single-ingredient formulation.

Blackstone Labs AbNORMAL Supplement Facts

Serving Size: 1 Tablet
Servings Per Container: 60
Container Size: 60 Tablets

19-NorDHEA Blend — 50 mg

• 19-NorAndrost-4-ene-3β-ol,17-one

• 19-NorAndrost-4-ene-3β-ol,17-one Decanoate

• 19-NorAndrost-4-ene-3β-ol,17-one Enanthate

† Daily Value not established.

Other Ingredients: Microcrystalline Cellulose, Phosphatidylcholine, Hydroxypropyl-Beta-Cyclodextrin, Phytosterol, Stearic Acid, Magnesium Stearate, Starch, Titanium Dioxide, Silica, FD&C Red #40, FD&C Blue #1.

The 50 mg amount represents the complete blend. Individual ingredient quantities are not disclosed.

Frequently Asked Questions

Q: What is Blackstone Labs AbNORMAL?

A: AbNORMAL is a prohormone supplement featuring three forms of 19-Nor-DHEA in a 50 mg proprietary blend. The formulation includes the base 19-nor precursor and its decanoate and enanthate derivatives.

Q: Is AbNORMAL the same as nandrolone or Deca-Durabolin?

A: No. AbNORMAL contains androgen precursors marketed as related to nandrolone metabolism. Deca-Durabolin is an injectable pharmaceutical preparation containing nandrolone decanoate. The two products are chemically and pharmacologically different.

Q: How many servings are in Blackstone Labs AbNORMAL?

A: Each bottle contains 60 tablets, with one tablet representing a labeled serving. Each tablet provides 50 mg of the combined 19-Nor-DHEA blend.

Safety and Regulatory Considerations

AbNORMAL contains androgen-related compounds that may produce clinically significant hormonal effects.

Potential risks associated with androgen precursors include suppression of endogenous hormone production, reproductive effects, adverse lipid changes, cardiovascular complications, androgen-related adverse effects, and possible liver injury.

The safety of this specific three-component formulation has not been established through controlled human clinical trials.

Claims that the formula is non-hepatotoxic, substantially more anabolic than testosterone, or free from significant adverse effects should not be accepted without appropriate clinical evidence.

The legal classification of individual steroid-related compounds and their status under athletic anti-doping regulations require separate verification.

Consult a qualified healthcare professional before considering products containing androgen precursors.